January 5, 2022
Nexium (esomeprazole) and Feburic (febuxostat) are among the major brands that are expected to be the targets of generic entries in 2022, Jiho has learned. With industry-wide supply disruptions still ongoing, however, companies are under pressure to exercise more caution...read more